Evidence map›Paper›PMID 14578255›Full record

ReviewDiabetes care2003

Follow-up report on the diagnosis of diabetes mellitus.

Saul Genuth, K G M M Alberti, Peter Bennett, John Buse, Ralph Defronzo, Richard Kahn, John Kitzmiller, William C Knowler, Harold Lebovitz, Ake Lernmark and 10 more

2 registry-linked trialsAbstract readConsensus StatementReview
PubMed Publisher
In one paragraph

Review in Diabetes care, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 1,208 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,208citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03658031 phase3unknown statusstarted 2019, after this paper: background citation

Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction

Ran2019Enrolled576Registered outcomes1Posted comparisons0ConditionsCVD, Myocardial Infarction, Prediabetes, T2DM (Type 2 Diabetes Mellitus)ArmsDapagliflozin 10mg
Open the trial in the graph
NCT03617757 nacompletednot on this mapstarted 2017, after this paper: background citation

Determinants of Progression From Impaired Fasting Glucose to Diabetes Mellitus Among Chinese - a 3-year Follow up Study

TypeinterventionalSponsorThe University of Hong KongRan2017 to 2019Enrolled386ConditionsProgression From Impaired Fasting Glucose to Diabetes MellitusArmsOral Glucose Tolerance Test, HbA1c
3 · Its place in the literature

Who cites it

1,208 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022
    Guideline
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Article
  20. Article

1,148 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Saul Genuth
K G M M Alberti
Peter Bennett
John Buse
Ralph Defronzo
Richard Kahn
John Kitzmiller
William C Knowler
Harold Lebovitz
Ake Lernmark
David Nathan
Jerry Palmer
Robert Rizza
Christopher Saudek
Jonathan Shaw
Michael Steffes
Michael Stern
Jaako Tuomilehto
Paul Zimmet
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Funding

Native Americans: Diabetes Mellitus/Chronic DiseasesZ01DK069000 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KNOWLER, WILLIAM C · 1986 to 2008
$680k
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood GlucoseDiabetes MellitusGlucose Tolerance TestGlycated HemoglobinHumansBlood GlucoseGlycated Hemoglobin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.